leadf
logo-loader
viewFaron Pharmaceuticals Ltd

Faron Pharmaceuticals applies to list shares on Nasdaq First North Growth Market

This provides investors in the company’s native Finland, many of whom backed the last fundraiser, to trade shares on a local exchange

Faron Pharmaceuticals Ltd -

Faron Pharmaceuticals Oy (LON:FARN) has applied to have its shares listed on the Nasdaq First North Growth Market.

This provides investors in the company’s native Finland, many of whom backed the last fundraiser, to trade shares on a local exchange.

Pending the application approval, the stock will begin trading on December 1.

Quick facts: Faron Pharmaceuticals Ltd

Price: 440 GBX

AIM:FARN
Market: AIM
Market Cap: £205.92 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Faron Pharmaceuticals Ltd named herein, including the promotion by the Company of Faron Pharmaceuticals Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: FTSE fragile Friday despite UK shoppers continuing to splurge...

Good morning, it’s a fragile Friday for the FTSE despite signs of some retail therapy as British retail sales continued to increase for the fourth consecutive month, boosted by spending on household goods and DIY, according to the ONS.  J Sainsbury PLC (LON:SBRY) is up after a...

2 days, 16 hours ago

2 min read